IN BRIEF (Page 14)

Sinopharm plans IPO

Sinopharm Holdings, majority owned by State-run China National Pharmaceutical Group, has got regulatory approval to list its shares in Hong Kong, Reuters reported yesterday, in an IPO that could raise up to 7 billion yuan. The parent company plans to list drug distributor Sinopharm in September and is now waiting for the Hong Kong exchange's approval, the report said.

Dongfeng Nissan output